Trial Profile
Efficacy of the Histone Deacetylase Inhibitor Chidamide in Combination With Antiretroviral Therapy for Reactivation of the Latent HIV-1 Reservoir:a Randomized Controlled Clinical Trial
Status:
Active, no longer recruiting
Phase of Trial:
Phase II/III
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Tucidinostat (Primary) ; Antiretrovirals
- Indications HIV-1 infections
- Focus Therapeutic Use
- 24 Apr 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Aug 2018.
- 08 Oct 2017 Status changed from recruiting to active, no longer recruiting.
- 28 Sep 2016 New trial record